詳細検索

詳細検索

お問い合わせ

Medical Device Technologies - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2027 - 2032)

Medical Device Technologies - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2027 - 2032)


Medical Device Technologies Market Analysis According to Mordor Intelligence, the medical device technologies market size is projected to expand from USD 0.73 trillion in 2026 and USD 0.78 tri... もっと見る

 

 

出版社
Mordor Intelligence
モードーインテリジェンス
出版年月
2026年10月22日
電子版価格
US$4,750
シングルユーザーライセンス
ライセンス・価格情報/注文方法はこちら
納期
3営業日以内
ページ数
185
言語
英語

英語原文をAIを使って翻訳しています。


 

Summary

Medical Device Technologies Market Analysis

According to Mordor Intelligence, the medical device technologies market size is projected to expand from USD 0.73 trillion in 2026 and USD 0.78 trillion in 2027 to USD 1.07 trillion by 2032, registering a CAGR of 6.62% between 2027 and 2032. This report is segmented by Device Type (Diagnostic Devices and more), Technology Platform (Conventional Electro-mechanical & Disposable and more), Therapeutic Application (Cardiology and more), End User (Hospitals and more), and Geography (North America and more). The market forecasts are provided in terms of value (USD), based on availability.

Global Medical Device Technologies Market Trends and Insights

Aging Population & Rise in Chronic Diseases

An expanding older population broadens the potential patient base for medical devices over several decades. The United Nations Department of Economic and Social Affairs estimated the global population aged 60 or older at 1.22 billion in 2025. It projected that this population would reach 2.11 billion by 2050. At about 1.7 times its 2025 size by 2050, the 60-and-over population gives suppliers of diagnostic, monitoring and implant equipment a patient base that keeps widening for 25 years.

Technological Convergence in Minimally Invasive & AI-Enabled Devices

AI integration can broaden the value of minimally invasive equipment by addressing a specific task within the surgical workflow. In March 2025, Moon Surgical received FDA clearance for ScoPilot, an optional AI-powered feature on its Maestro System. It allows an attached laparoscope to follow a selected instrument tip while the surgeon retains control of positioning without disengaging from the instruments. For operating teams, this links the value of the software to how the surgeon manages the view during a laparoscopic procedure. Because ScoPilot is an optional feature on the Maestro System, the clearance adds capability to an existing platform rather than introducing a separate surgical robot.

Stringent & Fragmented Regulatory Pathways

For smaller device manufacturers, complying with EU medical-device and in vitro diagnostic rules can absorb resources before a product generates a commercial return. The European Commission's 2025 evaluation found that 278 of 325 call-for-evidence entries discussing the regulations' impact on small and medium-sized enterprises addressed disproportionate financial and administrative burdens. This feedback makes certification and documentation demands commercially relevant because resources committed to market access cannot simultaneously support product development. The evaluation identifies high certification costs, resource constraints, lengthy approval timelines and complex documentation requirements as recurring SME concerns. The feedback connects these burdens with hindered innovation, possible product withdrawals and some SMEs leaving the market, making product availability vulnerable to compliance costs.

Other drivers and restraints analyzed in the detailed report include:

  1. Healthcare Infrastructure Expansion in Emerging Markets
  2. Rapid Uptake of Wearable & Remote-Monitoring Devices
  3. Reimbursement Cuts & Pricing Pressure

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Diagnostic devices accounted for a 39.03% share of the medical device technologies market size in 2026. Danaher Corporation's Diagnostics segment generated USD 9.94 billion in 2025 sales from clinical instruments, consumables, software and services used for disease diagnosis. Its customers include hospitals, physicians' offices, reference laboratories and other critical-care settings. This breadth gives the largest segment multiple points of contact with care delivery, connecting equipment demand to diagnostic work across several settings. Instrument placement and the consumables used with it provide complementary commercial roles, linking the supplier's equipment offering to the testing performed at these sites.

Monitoring devices are the fastest-growing segment, with a forecast CAGR of 6.93% between 2027 and 2032. Becton, Dickinson and Company (BD) reported USD 309 million in Advanced Patient Monitoring unit revenue for the quarter ended June 30, 2026, up 10.9% year over year. The unit reported portfolio volume growth driven particularly by Acumen IQ Cuff and Acumen IQ Sensor adoption and growth in consumables sales. Surgical devices have a different activity base, with Intuitive Surgical Inc.'s da Vinci systems used in approximately 3.15 million procedures worldwide in 2025. In monitoring, BD's reported growth rests on cuffs, sensors and consumables, while da Vinci procedure volumes indicate platform use rather than systems sold.

Conventional electromechanical and disposable technologies were the largest segment, accounting for 55.46% of revenue in 2026. BD's Medication Delivery Solutions unit generated USD 4.58 billion in global revenue in fiscal 2025. The company attributed unit volume growth to its vascular access management portfolio and hypodermic products. This connects conventional-device scale to the supply of established care products, with vascular access and hypodermic devices contributing to the unit's volume growth. An expected volume-based procurement impact in China partially offset that growth, placing a country-specific constraint on the unit's expansion.

Nanotechnology and smart materials form the fastest-growing segment, with a forecast CAGR of 7.85% between 2027 and 2032. Onkos Surgical received FDA 510(k) clearance in June 2026 to apply NanoCept technology to titanium implants in the ELEOS Limb Salvage System. Onkos describes the proprietary coating as non-eluting with a nanoscale surface, intended to reduce bacterial contamination on coated components before implantation. The commercial mechanism is differentiation at the implant surface, allowing a materials-based feature to become part of an established device offering. The clearance covers titanium implants in the ELEOS Limb Salvage System, and Onkos states that the coating's potential clinical impact has not been evaluated in human clinical studies.

Complete Report Scope:

  • By Device Type
    • Diagnostic Devices
      • Diagnostic Imaging Devices
        • MRI Systems
        • CT Scanners
        • Ultrasound
      • In-Vitro Diagnostics
    • Therapeutic Devices
      • Implants
      • Drug-Delivery Pumps
    • Surgical Devices
      • Robotics & Navigation
      • Energy-based Devices
    • Monitoring Devices
      • Multiparameter Monitors
      • Remote Patient Monitors
    • Others
  • By Technology Platform
    • Conventional Electro-mechanical & Disposable
    • Wearable & Remote Monitoring
    • Telehealth & mHealth
    • Robotic Surgery
    • 3-D Printing
    • Augmented / Virtual Reality
    • Nanotechnology & Smart Materials
    • AI-as-a-Medical-Device (SaMD)
  • By Therapeutic Application
    • Cardiology
    • Orthopedics & Sports Medicine
    • Neurology
    • Ophthalmology
    • General & Laparoscopic Surgery
    • Oncology
    • Others
  • By End User
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Home Healthcare Settings
    • Diagnostic Laboratories
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • Middle East and Africa
      • GCC
      • South Africa
      • Rest of Middle East and Africa
    • South America
      • Brazil
      • Argentina
      • Rest of South America

Geography Analysis

North America held a 45.26% medical device technologies market share in 2026, making it the largest geography. Under its October 6, 2026 partnership with the US government, Becton, Dickinson and Company intended to expand US end-to-end production by approximately 5 billion essential medical consumables annually. Siemens Healthineers AG reported 17,207 US employees in active employment across its fully consolidated companies at fiscal 2025 year-end. Its Cary, North Carolina, training center offers more than 1,000 imaging and laboratory diagnostic equipment courses, pairing this US operating footprint with technical education for hospital and laboratory engineering teams.

Asia-Pacific is the fastest-growing geography, with a forecast CAGR of 7.4% between 2027 and 2032. Manufacturers participating in India's Production Linked Incentive scheme had begun producing 57 unique medical devices by September 2026, including MRI machines, CT scanners and heart valves. The program established domestic capabilities for high-end devices that had previously been predominantly imported. This gives the regional growth mechanism a supply-side dimension, as local production broadens the range of equipment that can be sourced from participating manufacturers. The commercial opening is a more diverse domestic manufacturing base, spanning imaging and implant technologies within the scheme's participating producers.

Europe's medical-technology industry included more than 36,000 companies in 2025, around 90% of them small and medium-sized enterprises, so most suppliers in the region operate at small scale. In the Middle East and Africa, the Saudi Food and Drug Authority reported 25 licensed medical-device factories and 1,313 licensed medical-device warehouses in Saudi Arabia in 2025. Kenya's Ministry of Health set a 2026-2030 strategy to expand local health-products manufacturing, including medical devices, and develop regional markets for Kenyan manufacturers. In South America, Brazil's AgSUS began primary-care equipment procurement processes in the second half of 2025, coordinating tenders, supplier contracting and distribution logistics with the Ministry of Health. Kenya's plan targets local manufacturing for regional markets, Saudi Arabia's licensed base covers both factories and warehouses, and Brazil's coordinated procurement gives suppliers a public channel to participating municipalities.

List of Companies Covered in this Report:

  1. Abbott Laboratories
  2. Baxter
  3. Beckton Dickinson
  4. Boston Scientific
  5. Canon
  6. Cardinal Health
  7. Danaher
  8. Dexcom
  9. Edward Lifesciences
  10. FUJIFILM
  11. GE HealthCare Technologies Inc.
  12. Hologic
  13. Intuitive Surgical
  14. Johnson & Johnson
  15. Medtronic
  16. Olympus
  17. Koninklijke Philips
  18. Resmed
  19. Roche
  20. Siemens Healthineers
  21. Smiths Group
  22. Stryker
  23. Terumo
  24. Zimmer Biomet

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support


ページTOPに戻る


Table of Contents

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE
4.1 Market Overview
4.2 Market Drivers
4.2.1 Aging Population & Rise in Chronic Diseases
4.2.2 Technological Convergence in Minimally Invasive & AI-Enabled Devices
4.2.3 Healthcare Infrastructure Expansion in Emerging Markets
4.2.4 Rapid Uptake of Wearable & Remote-Monitoring Devices
4.2.5 Digital Twins & In-Silico Trials Shortening R&D Cycles
4.2.6 Point-Of-Care 3-D Printing Enabling Just-In-Time Implants
4.3 Market Restraints
4.3.1 Stringent & Fragmented Regulatory Pathways
4.3.2 Reimbursement Cuts & Pricing Pressure
4.3.3 Cyber-Security Liability Shifts Raising Compliance Costs
4.3.4 Rare-Earth Material Supply Constraints for Imaging Components
4.4 Industry Value Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces Analysis
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Suppliers
4.7.3 Bargaining Power of Buyers
4.7.4 Threat of Substitutes
4.7.5 Competitive Rivalry

5 MARKET SIZE AND GROWTH FORECASTS (VALUE)
5.1 By Device Type
5.1.1 Diagnostic Devices
5.1.1.1 Diagnostic Imaging Devices
5.1.1.1.1 MRI Systems
5.1.1.1.2 CT Scanners
5.1.1.1.3 Ultrasound
5.1.1.2 In-Vitro Diagnostics
5.1.2 Therapeutic Devices
5.1.2.1 Implants
5.1.2.2 Drug-Delivery Pumps
5.1.3 Surgical Devices
5.1.3.1 Robotics & Navigation
5.1.3.2 Energy-based Devices
5.1.4 Monitoring Devices
5.1.4.1 Multiparameter Monitors
5.1.4.2 Remote Patient Monitors
5.1.5 Others
5.2 By Technology Platform
5.2.1 Conventional Electro-mechanical & Disposable
5.2.2 Wearable & Remote Monitoring
5.2.3 Telehealth & mHealth
5.2.4 Robotic Surgery
5.2.5 3-D Printing
5.2.6 Augmented / Virtual Reality
5.2.7 Nanotechnology & Smart Materials
5.2.8 AI-as-a-Medical-Device (SaMD)
5.3 By Therapeutic Application
5.3.1 Cardiology
5.3.2 Orthopedics & Sports Medicine
5.3.3 Neurology
5.3.4 Ophthalmology
5.3.5 General & Laparoscopic Surgery
5.3.6 Oncology
5.3.7 Others
5.4 By End User
5.4.1 Hospitals
5.4.2 Clinics
5.4.3 Ambulatory Surgical Centers
5.4.4 Home Healthcare Settings
5.4.5 Diagnostic Laboratories
5.5 By Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 India
5.5.3.3 Japan
5.5.3.4 South Korea
5.5.3.5 Australia
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Share Analysis
6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
6.4.1 Abbott Laboratories
6.4.2 Baxter International Inc.
6.4.3 Becton, Dickinson and Company
6.4.4 Boston Scientific Corporation
6.4.5 Canon Medical Systems Corporation
6.4.6 Cardinal Health Inc.
6.4.7 Danaher Corporation
6.4.8 Dexcom Inc.
6.4.9 Edwards Lifesciences Corporation
6.4.10 Fujifilm Holdings Corporation
6.4.11 GE HealthCare Technologies Inc.
6.4.12 Hologic Inc.
6.4.13 Intuitive Surgical Inc.
6.4.14 Johnson & Johnson
6.4.15 Medtronic plc
6.4.16 Olympus Corporation
6.4.17 Philips Healthcare
6.4.18 ResMed Inc.
6.4.19 Roche Diagnostics
6.4.20 Siemens Healthineers AG
6.4.21 Smith & Nephew plc
6.4.22 Stryker Corporation
6.4.23 Terumo Corporation
6.4.24 Zimmer Biomet Holdings Inc.

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK
7.1 White-Space and Unmet-Need Assessment

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


Mordor Intelligence社はどのような調査会社ですか?


Mordor Intelligenceは世界の多様な市場に関する重要動向、技術、競争、機会について調査しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2026/11/18 10:26

160.63 円

176.84 円

214.73 円

ページTOPに戻る